Core Viewpoint - Hongyuan Pharmaceutical (301246.SZ) is currently trading at 21.20 yuan, reflecting a decline of 2.66% and is in a state of breaking its initial public offering price [1] Group 1: IPO Details - Hongyuan Pharmaceutical was listed on the Shenzhen Stock Exchange's ChiNext board on March 20, 2023, with an initial public offering of 47.2572 million shares at a price of 50.00 yuan per share [1] - On its first trading day, the stock reached a peak price of 45 yuan, marking the highest price since its listing [2] - The total amount raised from the IPO was 236.286 million yuan, with a net amount of 219.58437 million yuan after deducting issuance costs, exceeding the original plan by 154.51137 million yuan [2] Group 2: Fund Utilization - The company planned to use the raised funds of 65.073 million yuan for projects including a research center, multifunctional testing workshop, antiviral raw materials and intermediates project, and a high-end formulation workshop with an annual production capacity of 2.5 billion tablets (or granules) [2] - The total issuance costs for the IPO amounted to 16.70163 million yuan, with underwriting and sponsorship fees accounting for 13.93196 million yuan [2]

Group 1 - The core point of the article is that Riheng Technology (688531.SH) has experienced a decline in stock price, closing at 65.80 yuan, a decrease of 2.05% [1] - Riheng Technology was listed on the Shanghai Stock Exchange's Sci-Tech Innovation Board on March 31, 2023, with an initial public offering of 19.85 million shares at a price of 152.38 yuan per share [1] - The stock reached its highest price of 241.11 yuan on its first trading day but is currently in a state of decline [1] Group 2 - The total amount raised from the initial public offering was 302.50 million yuan, with a net amount of 273.08 million yuan, exceeding the original plan by 213.08 million yuan [1] - The company planned to use the raised funds for projects including X-ray source industrialization, construction of a production base in Chongqing, and a research and development center [1] - The total issuance costs for the initial public offering amounted to 29.42 million yuan, excluding tax, with underwriting fees of 26.18 million yuan [1] Group 3 - Riheng Technology announced a dividend plan on May 31, 2024, proposing a stock bonus of 4.5 shares for every 10 shares held and a pre-tax dividend of 8 yuan [2] - Another dividend plan was released on July 4, 2025, with a similar stock bonus of 4.5 shares for every 10 shares and a pre-tax dividend of 6 yuan [3]

Core Points - HeMai Co., Ltd. (688032.SH) closed at 109.85 yuan, with a decline of 1.16% on September 22, 2023, marking three consecutive trading days of losses [1] - The stock is currently in a state of breaking below its initial public offering (IPO) price of 557.80 yuan per share, which was set during its listing on the Shanghai Stock Exchange's Sci-Tech Innovation Board on December 20, 2021 [1] - The total amount raised from the IPO was 5.578 billion yuan, with a net amount of 5.406 billion yuan after deducting issuance costs, exceeding the original plan by 4.848 billion yuan [1] Financial Information - The total issuance costs for the IPO amounted to 172 million yuan, with underwriting and sponsorship fees accounting for 142 million yuan [2] - HeMai Co., Ltd. announced dividend plans, including a distribution of 30 yuan per 10 shares in May 2022, 53 yuan per 10 shares in June 2023, and a planned 36 yuan per 10 shares in June 2024, along with stock bonuses [2]

Group 1 - The stock price of Arctech (688472.SH) fell by 3.56% to 8.93 yuan as of the market close on July 31, 2023, indicating that the stock is currently in a state of decline since its IPO [1] - Arctech was listed on the Shanghai Stock Exchange's Sci-Tech Innovation Board on June 9, 2023, with an initial public offering (IPO) price of 11.10 yuan per share. The total number of shares issued before the full exercise of the over-allotment option was 541,058,824 shares, accounting for 15.00% of the total share capital post-issue [1] - After the full exercise of the over-allotment option, the total number of shares issued increased to 622,217,324 shares, representing 16.87% of the total share capital post-issue [1][2] Group 2 - The total amount of funds raised from the IPO was 600,575.29 million yuan before the exercise of the over-allotment option and 690,661.23 million yuan after the full exercise [1][2] - The net amount raised after deducting issuance costs was 572,782.43 million yuan before the over-allotment option and 662,845.46 million yuan after the full exercise [1][2] - The final net amount raised exceeded the original plan by 172,782.43 million yuan before the over-allotment option and 262,845.46 million yuan after the full exercise [2] Group 3 - The total issuance costs for the IPO were 27,792.86 million yuan before the over-allotment option and 27,815.77 million yuan after the full exercise, with underwriting and sponsorship fees amounting to 17,264.15 million yuan [3] - The actual controllers of Arctech are Xiaohua Qu and his spouse Han Bing Zhang, both of whom hold Canadian nationality [4]

Group 1 - The stock of Mannester (301325.SZ) closed at 59.08 RMB, reflecting a decline of 3.35% and is currently in a state of underperformance [1] - Mannester was listed on the Shenzhen Stock Exchange's ChiNext board on May 12, 2023, with an initial public offering (IPO) of 30 million shares at a price of 76.80 RMB per share [1] - The total funds raised from the IPO amounted to 230.4 million RMB, with a net amount of 210.69 million RMB, exceeding the original plan by 157.60 million RMB [1] Group 2 - Mannester's 2023 annual equity distribution plan includes a cash dividend of 5.00 RMB for every 10 shares, based on a total share capital of 119,463,300 shares after excluding 536,700 repurchased shares [2] - Additionally, the company plans to increase capital by issuing 2 new shares for every 10 shares held, funded by the capital reserve [2] - The record date for the equity distribution is set for May 23, 2024, with the ex-dividend date on May 24, 2024 [2]

Group 1 - The core viewpoint of the articles highlights the financial performance and stock market status of Suochen Technology, which is currently facing a decline in stock price since its IPO [1] - Suochen Technology's stock closed at 77.33 yuan, reflecting a drop of 6.27%, with a total market capitalization of 6.891 billion yuan [1] - The company went public on April 18, 2023, with an initial offering price of 245.56 yuan per share, indicating that the stock is currently in a state of decline [1] Group 2 - The company raised a total of 253.75 million yuan through its IPO, with a net amount of 231.57 million yuan, exceeding the original plan by 134.68 million yuan [1] - The funds raised are allocated for various projects, including the construction of a research and development center and the production of underwater noise testing instruments [1] - The underwriting fees for the IPO amounted to 22.17 million yuan, with the main underwriter being Haitong Securities [1] Group 3 - Suochen Technology announced a cash dividend of 0.15 yuan per share and a capital increase of 0.48 shares per share based on a total share capital of 41,333,400 shares [2] - The total cash dividend distributed was 6.20 million yuan, and the capital increase resulted in an additional 19.84 million shares, bringing the total share capital to 61,173,432 shares [2] - For the 2023 annual profit distribution, the company plans to distribute a cash dividend of 3.80 yuan for every 10 shares and a capital increase of 4.60 shares for every 10 shares [2]